Additionally, IL-1β has a substantial role in lung cancer development via regulation of tumor growth, invasiveness, and angiogenesis, which were demonstrated in a clinical study using the anti-IL-1β antibody canakinumab [36]. Here, IL1B is linked to lung cancer.